SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zoetis Inc. (ZTS) trades at a trailing P/E of 19.3, forward P/E of 17.2. Trailing earnings yield is 5.18%, forward earnings yield 5.80%. PEG 1.91. Graham Number is $32.30.
Criteria proven by this page:
- VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 17.2 (down from trailing 19.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.91 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 5.18% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 5.80% as earnings recover.
- Analyst consensus target $143.86 (+18.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 71/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZTS
Valuation Multiples
P/E (TTM)19.3
Forward P/E17.2
PEG Ratio1.91
Forward PEG1.03
P/B Ratio15.48
P/S Ratio5.48
EV/EBITDA14.4
Per Share Data
EPS (TTM)$6.10
Forward EPS (Est.)$7.02
Book Value / Share$7.60
Revenue / Share$21.60
FCF / Share$5.21
Yields & Fair Value
Earnings Yield5.18%
Forward Earnings Yield5.80%
Dividend Yield1.73%
Graham Number$32.30
SharesGrow IV$130.84 (+8%)
Analyst Target$143.86 (+18.8%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
32.3 |
0.22 |
17.85 |
5.43 |
0.71% |
| 2017 |
40.8 |
6.78 |
19.94 |
6.65 |
0.58% |
| 2018 |
28.9 |
0.42 |
18.91 |
7.09 |
0.59% |
| 2019 |
42.2 |
6.94 |
23.37 |
10.11 |
0.50% |
| 2020 |
48.0 |
5.03 |
20.88 |
11.79 |
0.48% |
| 2021 |
56.8 |
2.30 |
25.48 |
14.89 |
0.41% |
| 2022 |
32.5 |
6.34 |
15.60 |
8.50 |
0.89% |
| 2023 |
38.8 |
3.07 |
18.22 |
10.65 |
0.76% |
| 2024 |
29.8 |
3.88 |
15.51 |
8.00 |
1.06% |
| 2025 |
20.9 |
2.04 |
16.75 |
5.89 |
1.59% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.65 |
$4.89B |
$821M |
16.8% |
| 2017 |
$1.75 |
$5.31B |
$864M |
16.3% |
| 2018 |
$2.93 |
$5.83B |
$1.43B |
24.5% |
| 2019 |
$3.11 |
$6.26B |
$1.5B |
24% |
| 2020 |
$3.42 |
$6.68B |
$1.64B |
24.5% |
| 2021 |
$4.27 |
$7.78B |
$2.04B |
26.2% |
| 2022 |
$4.49 |
$8.08B |
$2.11B |
26.2% |
| 2023 |
$5.07 |
$8.54B |
$2.34B |
27.4% |
| 2024 |
$5.47 |
$9.26B |
$2.49B |
26.9% |
| 2025 |
$6.02 |
$9.47B |
$2.67B |
28.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.02 |
$6.73 – $7.08 |
$9.91B |
$9.84B – $10B |
12 |
| 2027 |
$7.56 |
$7.29 – $7.86 |
$10.39B |
$10.22B – $10.63B |
12 |
| 2028 |
$8.18 |
$7.76 – $8.48 |
$10.92B |
$10.92B – $10.92B |
5 |
| 2029 |
$8.72 |
$8.58 – $8.91 |
$11.38B |
$11.24B – $11.57B |
1 |
| 2030 |
$9.27 |
$9.12 – $9.47 |
$11.86B |
$11.71B – $12.05B |
1 |
